Unlocking the differences and overlaps between infertility with and without endometriosis is critical to better answers, earlier interventions, and more compassionate care. At NextGen Jane, we are working to change the way these conditions are studied and diagnosed. Our tampon-based test is working to detect molecular signatures in menstruation, no surgery or extensive medical workup required. By comparing those with infertility linked to endometriosis against those struggling without it, we aim to uncover patterns that traditional methods have missed. You can be part of advancing this research and shaping the future of fertility care.
With 1000s of tampons collected, NextGen Jane is creating the world’s largest menstrual blood biobank. NextGen Jane is using this biobank to develop tampon-based diagnostics for infertility and endometriosis.
We need to collect tampons from patients who qualify. All participants must reside in the US, have routine menstrual cycles, and have struggled to get pregnant:
In addition, you must fit one of the following categories:
Endometriosis Confirmed
Endometriosis Not Suspected
Endometriosis Suspected/Post-Lap (Enrolling with Low Priority):
Your participation can transform an often-overlooked aspect of women’s health by utilizing something that is normally discarded.
To acknowledge your contribution, you will receive a $25 digital Amazon gift card for each tampon provided, up to a study maximum of $500.
Together, we can revolutionize how reproductive health conditions are diagnosed and managed. Thank you for helping to reshape healthcare for the next generation.
You can be a part of our study to establish how well our test works for people struggling with infertility.